Delineating Pro-Angiogenic Myeloid Cells in Cancer Therapy

Recent evidence suggests that myeloid cells are critical in cancer development and therapy resistance processes. Pharmacological targeting of tumor-associated myeloid cells is an emerging approach among upcoming immune therapies. Surprisingly, myeloid cells are heterogeneous, including a subset of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Benjamin W., Achyut, Bhagelu R., Fulzele, Sadanand, Mondal, Ashis K., Kolhe, Ravindra, Arbab, Ali S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165286/
https://www.ncbi.nlm.nih.gov/pubmed/30158456
http://dx.doi.org/10.3390/ijms19092565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165286/
https://www.ncbi.nlm.nih.gov/pubmed/30158456
http://dx.doi.org/10.3390/ijms19092565

Ejemplares similares